Related to this topic: Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Krabbe's Disease

Synonyms: Globoid cell leukodystrophy; Globoid cell leukoencephalopathy; Galactosylceramide lipidosis; Galactosylceramidase (GALC) deficiency

An autosomal recessive condition which is often fatal, resulting in lack of the enzyme galatosylceramidase leading to abnormalities of myelin formation affecting both the central and peripheral nervous system. It is a member of the leukodystrophies.

There are two types of presentation

  1. Infantile form - the commonest with infants developing features in the first 6 months of life
  2. Late-onset form - later presentation including adulthood, more rare but progression is slower

Worldwide it is estimated to affect 1 in 100,000 - 200,000 births although a higher incidence occurs in some certain groups e.g. some Israeli communities. Males and females are equally affected with 80% of cases being diagnosed by 6 months of age.

Aetiology

The mutation in Krabbe disease is located to the human chromosome 14 and more than 40 mutations have been identified.1 This mutation of the GALC gene leads to a deficiency of galactosylceramidase. Deficiency of this enzyme leads to an inability to breakdown lipids in the myelin leading to reduced myelin production. However, it has been observed that this genotype alone may not account for the phenotype suggesting that other genetic factors may also be important.1,2

Presentation

Affected infants are normal at birth.

Symptoms occur at 3-6 months

  • Irritability
  • Crying
  • Fever
  • Feeding difficulties
  • Limb stiffness
  • Delayed achievement of milestones
  • Vomiting
  • Blindness
  • Seizures

Signs

The late onset forms have similar features but these progress slower and can be milder. Adults commonly present with motor skill problems, paraesthesia, weakness and cognitive deficits.

Differential diagnosis
Investigations
  • Galactosylceramidase (GALC) enzyme activity - from blood or skin fibroblasts (activity reduced)
  • MRI - demyelination of white matter of brain and more rarely the spinal cord3
  • Lumbar puncture will show raised CSF protein
  • Nerve conduction - can be normal; but most have some abnormalities e.g. delayed brainstem auditory evoked potentials and visual evoked potentials
  • Histology - presence of PAS- positive material extracellularly and cerithin in microglial cells with characteristic "globoid cells" in brain tissue1
  • EEG
  • Genetic studies
Prenatal diagnosis

This can be performed with chorionic villous sampling.1

Management
  • There is no cure yet and thus management is mainly supportive e.g. physiotherapy, anti-convulsants.
  • Allogeneic haematopoietic stem cell transplantation in early disease leads to reversal of CNS deterioration.4,5
  • Transplantation of umbilical cord blood from unrelated donors leads to neurological improvement in those who received this therapy before the development of symptoms.6

Parents and carers will need education and support. Parents will require counselling before further pregnancies

Prognosis

Poor in infantile forms with death usually before the age of 2 years. However, some cases have been reported to live beyond the teens. In late onset disease cases progress more slower and the spectrum and severity of the illness is also very variable.


Document References
  1. OMIM - Krabbe's Disease
  2. Xu C, Sakai N, Taniike M, et al; Six novel mutations detected in the GALC gene in 17 Japanese patients with Krabbe disease, and new genotype-phenotype correlation. J Hum Genet. 2006;51(6):548-54. Epub 2006 Apr 11. [abstract]
  3. Given CA 2nd, Santos CC, Durden DD; Intracranial and spinal MR imaging findings associated with Krabbe's disease: case report. AJNR Am J Neuroradiol. 2001 Oct;22(9):1782-5. [abstract]
  4. Siddiqi ZA, Sanders DB, Massey JM; Peripheral neuropathy in Krabbe disease: effect of hematopoietic stem cell transplantation. Neurology. 2006 Jul 25;67(2):268-72. [abstract]
  5. McGraw P, Liang L, Escolar M, et al; Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements--initial experience. Radiology. 2005 Jul;236(1):221-30. [abstract]
  6. Escolar ML, Poe MD, Provenzale JM, et al; Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease. N Engl J Med. 2005 May 19;352(20):2069-81. [abstract]
Acknowledgements EMIS is grateful to Dr Gurvinder Rull for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 2365
Document Version: 21
DocRef: bgp1791
Last Updated: 22 Mar 2007
Review Date: 21 Mar 2009


















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site














Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page